Medicine and Dentistry
Antiinfective Agent
8%
B-Cell Lymphoma
8%
Bladder Cancer
100%
Breast Cancer
8%
Bruton Tyrosine Kinase
100%
Bruton Tyrosine Kinase Inhibitor
16%
Cancer Cell
100%
Cancer Growth
25%
Carboplatin
100%
Cell Viability
8%
Cytotoxicity
100%
Genetic Transfection
8%
Glioblastoma
8%
Ibrutinib
25%
In Vitro
16%
Malignant Neoplasm
100%
mTOR Signaling
8%
Short Hairpin RNA
8%
Side Population
8%
Side Population Cell
8%
Solid Malignant Neoplasm
8%
Survival Analysis
8%
Therapy Effect
8%
Tumor Spheroid
8%
Pharmacology, Toxicology and Pharmaceutical Science
Antiinfective Agent
8%
B Cell Lymphoma
8%
Bladder Cancer
100%
Breast Cancer
8%
Bruton Tyrosine Kinase
100%
Bruton Tyrosine Kinase Inhibitor
16%
Cancer Growth
25%
Carboplatin
100%
Cell Viability
8%
Cytotoxicity
100%
Glioblastoma
8%
Ibrutinib
25%
Malignant Neoplasm
100%
Short Hairpin RNA
8%
Solid Malignant Neoplasm
8%
Therapeutic Effect
8%
Biochemistry, Genetics and Molecular Biology
B Cell
8%
Bruton Tyrosine Kinase
100%
Cancer Cell
100%
CD133
8%
Cell Viability
8%
Cytotoxicity
100%
Ibrutinib
25%
mTOR Signaling
8%
Side Population
16%
Small Hairpin RNA
8%
Transfection
8%
Tumor Spheroid
8%
Tyrosine Kinase Inhibitor
16%